ACELLYTRON Trademark
Trademark Overview
On Tuesday, November 28, 2023, a trademark application was filed for ACELLYTRON with the United States Patent and Trademark Office. The USPTO has given the ACELLYTRON trademark a serial number of 79392046. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 29, 2025. This trademark is owned by Wuxi Biologics (Shanghai) Co., Ltd.. The ACELLYTRON trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Chemical-pharmaceutical preparations for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; biochemical medicines for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; drugs for medical purposes, namely medicines for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-r...
Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies
Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance
Research and development of new products for others; technological research in the field of pharmaceutical studies, cell separation and cell culture; chemical analysis; biochemistry research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely conducting clinical trials for others; biological research; computer programming in the field of medical aspects
General Information
| Serial Number | 79392046 |
| Word Mark | ACELLYTRON |
| Filing Date | Tuesday, November 28, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, April 29, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 29, 2025 |
Trademark Statements
| Goods and Services | Chemical-pharmaceutical preparations for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; biochemical medicines for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; drugs for medical purposes, namely medicines for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; pharmaceutical preparations for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely biologic preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; oncolytic viral therapies; medical cell inhibitor, namely protein, antibody and small molecule inhibitor; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely tumor suppressor; cells for medical use; dietetic food and substances adapted for medical use; biological preparations for veterinary purposes for the treatment of blood cancer, solid tumor, cancer or tumor, autoimmune disease, non-communicable diseases, Neurodegenerative diseases, aging-related diseases, coagulation disorder and infectious disease |
| Goods and Services | Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies |
| Goods and Services | Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance |
| Goods and Services | Research and development of new products for others; technological research in the field of pharmaceutical studies, cell separation and cell culture; chemical analysis; biochemistry research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely conducting clinical trials for others; biological research; computer programming in the field of medical aspects |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 23, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Wuxi Biologics (Shanghai) Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
| Party Name | Wuxi Biologics (Shanghai) Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CN |
Trademark Events
| Event Date | Event Description |
| Wednesday, March 27, 2024 | APPLICATION FILING RECEIPT MAILED |
| Thursday, July 18, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, July 18, 2024 | REFUSAL PROCESSED BY MPU |
| Sunday, August 11, 2024 | REFUSAL PROCESSED BY IB |
| Thursday, March 21, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, March 23, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 26, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 26, 2024 | ASSIGNED TO EXAMINER |
| Thursday, June 27, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, October 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, October 10, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 13, 2025 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, January 13, 2025 | FINAL REFUSAL E-MAILED |
| Monday, January 13, 2025 | FINAL REFUSAL WRITTEN |
| Friday, February 21, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, February 21, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 21, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, April 1, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 23, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 29, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 29, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
